133 related articles for article (PubMed ID: 17361979)
1. Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
Amon M; Ligneau X; Camelin JC; Berrebi-Bertrand I; Schwartz JC; Stark H
ChemMedChem; 2007 May; 2(5):708-16. PubMed ID: 17361979
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent non-imidazole histamine H3 receptor ligands with nanomolar affinities.
Amon M; Ligneau X; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2006 Apr; 16(7):1938-40. PubMed ID: 16434192
[TBL] [Abstract][Full Text] [Related]
3. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
[TBL] [Abstract][Full Text] [Related]
4. Piperidine variations in search for non-imidazole histamine H(3) receptor ligands.
Łazewska D; Kuder K; Ligneau X; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2008 Sep; 16(18):8729-36. PubMed ID: 18774720
[TBL] [Abstract][Full Text] [Related]
5. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
[TBL] [Abstract][Full Text] [Related]
6. Search for histamine H(3) receptor ligands with combined inhibitory potency at histamine N-methyltransferase: omega-piperidinoalkanamine derivatives.
Grassmann S; Apelt J; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
Arch Pharm (Weinheim); 2004 Oct; 337(10):533-45. PubMed ID: 15476285
[TBL] [Abstract][Full Text] [Related]
7. Cyclopropane-based stereochemical diversity-oriented conformational restriction strategy: histamine H3 and/or H4 receptor ligands with the 2,3-methanobutane backbone.
Watanabe M; Kobayashi T; Hirokawa T; Yoshida A; Ito Y; Yamada S; Orimoto N; Yamasaki Y; Arisawa M; Shuto S
Org Biomol Chem; 2012 Jan; 10(4):736-45. PubMed ID: 22120611
[TBL] [Abstract][Full Text] [Related]
8. Diether derivatives of homo- or substituted piperidines as non-imidazole histamine H3 receptor ligands.
Łazewska D; Kuder K; Ligneau X; Camelin JC; Schunack W; Stark H; Kieć-Kononowicz K
Bioorg Med Chem; 2009 Apr; 17(8):3037-42. PubMed ID: 19329325
[TBL] [Abstract][Full Text] [Related]
9. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
[TBL] [Abstract][Full Text] [Related]
10. Acidic elements in histamine H(3) receptor antagonists.
Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
[TBL] [Abstract][Full Text] [Related]
11. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
[TBL] [Abstract][Full Text] [Related]
12. Fluorinated non-imidazole histamine H3 receptor antagonists.
Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
[TBL] [Abstract][Full Text] [Related]
13. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.
Mezzomo K; Cumming P; Minuzzi L
Eur J Pharmacol; 2007 Jun; 564(1-3):75-9. PubMed ID: 17350614
[TBL] [Abstract][Full Text] [Related]
15. 2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterization.
Sander K; Kottke T; Tanrikulu Y; Proschak E; Weizel L; Schneider EH; Seifert R; Schneider G; Stark H
Bioorg Med Chem; 2009 Oct; 17(20):7186-96. PubMed ID: 19773175
[TBL] [Abstract][Full Text] [Related]
16. Tritium-labeled N(1)-[3-(1H-imidazol-4-yl)propyl]-N(2)-propionylguanidine ([(3)H]UR-PI294), a high-affinity histamine H(3) and H(4) receptor radioligand.
Igel P; Schnell D; Bernhardt G; Seifert R; Buschauer A
ChemMedChem; 2009 Feb; 4(2):225-31. PubMed ID: 19101971
[TBL] [Abstract][Full Text] [Related]
17. Diether (substituted) piperidine derivatives as novel, histamine H3 receptor ligands.
Kuder KJ; Ligneau X; Camelin JC; Lazewska D; Schwartz JC; Schunack W; Stark H; Kieć-Kononowicz K
Inflamm Res; 2009 Apr; 58 Suppl 1():47-8. PubMed ID: 19266264
[No Abstract] [Full Text] [Related]
18. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
Morini G; Comini M; Rivara M; Rivara S; Bordi F; Plazzi PV; Flammini L; Saccani F; Bertoni S; Ballabeni V; Barocelli E; Mor M
Bioorg Med Chem; 2008 Dec; 16(23):9911-24. PubMed ID: 18976927
[TBL] [Abstract][Full Text] [Related]
19. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
Frymarkiewicz A; Walczyński K
Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
[TBL] [Abstract][Full Text] [Related]
20. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]